Last reviewed · How we verify
NCT05875987
Evaluation of the Quantra QStat System in Obstetric Patients
trial testing Quantra System in Blood Loss Massive in 50 participants. Completed in 10 May 2024.
31 March 2024
Quick facts
| Lead sponsor | HemoSonics LLC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 June 2023 |
| Primary completion | 31 March 2024 |
| Estimated completion | 10 May 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Quantra System
Conditions studied
- Blood Loss Massive — all drugs for Blood Loss Massive →
- Post Operative Hemorrhage — all drugs for Post Operative Hemorrhage →
Sponsor
HemoSonics LLC — full company profile →
Who can join
18 and older, female only, with Blood Loss Massive or Post Operative Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in bleeding pregnant women at delivery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05875987
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Quantra System
Trials testing the same drug.
- NCT07447713 — Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients · not yet recruiting
- NCT06415760 — Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients · completed
- NCT05426564 — Exploratory Assessment of the Quantra® System in Adult ECMO Patients · completed
- NCT04460664 — Coagulation Changes Associated With COVID-19 Infection · completed
- NCT04312958 — Quantra QStat in Trauma and Liver Transplant · completed
Other HemoSonics LLC trials
Trials by the same sponsor.
- NCT07447713 — Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients · not yet recruiting
- NCT06255496 — QStat Cartridge in Obstetric Patients · completed
- NCT06415760 — Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients · completed
- NCT06025708 — Quantra QStat Sample Type Comparison · completed
- NCT05645133 — QPlus Pediatric Reference Interval · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05875987 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HemoSonics LLC
- Last refreshed: 13 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05875987.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing